New information regarding use as first line therapy in conjunction with systemic chemotherapy.

Hepatic yttrium-90 radioembolization, also known as selective internal radiation therapy (SIRT), is a form of brachytherapy used to treat primary and secondary liver tumors.  This therapy is analogous to the perhaps better known chemoembolization procedure, with the difference being tiny 50 micron particles containing the beta radiation emitter yttrium-90 are infused into the hepatic artery instead of chemotherapeutic agents. Read More.